November 30, 2020

The Niche

Knoepfler lab stem cell blog

Search Results for: geron

3 min read

BioTime (BTX), via its subsidiary Asterias, has formally purchased the Geron (GERN) embryonic stem cell (ESC) research program and assets. Incidentally, Asterias in nature refers to a genus of sea stars including starfish and you can see it in their logo. Perhaps this was chosen given the amazing regenerative capacity of starfish? You may recall that Geron decided not to continue its ESC program despite having an active, FDA approved early clinical trial underway. There was great concern that the program could die, but …Read More

3 min read

When you want to both know the real history of the pluripotent stem cell-based biotech industry and perspectives on its future, there are only a handful of people to turn to and one of them is definitely Dr. Michael West, CEO of BioTime. I’m doing a several part series of blog posts on a lengthy phone interview and conversation that I had with West. Today in Part 2 we are focused on clinical development of human ES cells and what happened with Geron. You …Read More

2 min read

When biotech Geron punted on its embryonic stem cell (ESC) program despite having an ongoing FDA-approved clinical trial for spinal cord injury and tens of millions in loan funding from CIRM, many in the stem cell field were upset to put it mildly. Geron repaid the CIRM loan with interest. At the time, the general feeling was that the odds of another company picking up the ESC program from Geron were low. However, ever since, rumors have gradually been popping up more and more …Read More

2 min read

Last year one of the biggest events in the stem cell field was biotech Geron punting its embryonic stem cell (ESC) program. Much consternation followed. Some folks opposed to ESCs happily pronounced ESC research dead. Some folks in favor of ESC thought the world was ending a year early. Others tried to look on the bright side and hoped for a buyer for Geron’s ESC-related assets, but through the grapevine everything I was hearing was that that was not going to happen. Now that …Read More